Emerging Markets Earnings Roundup: Eli Lilly (Part 8)
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly soldiers on in emerging markets as a key focus area, as the U.S. firm deals with a steep patent cliff and looks to a diverse pipeline to join its growing animal health business as an earnings driver.